Antibody data
- Antibody Data
- Antigen structure
- References [13]
- Comments [0]
- Validations
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN151866 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Solute Carrier Family 31 (Copper Transporters), Member 1 (SLC31A1) (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human, Mouse, Rat, Porcine, Xenopus, Zebrafish
- Host
- Rabbit
- Epitope
- C-Term
- Vial size
- 0.1 mL
- Storage
- Store at 4°C. Do not freeze.
- Handling
- Do not freeze.
Submitted references Transporter-Mediated Interaction Between Platinum Drugs and Sorafenib at the Cellular Level.
Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells.
Evaluation of effects of copper histidine on copper transporter 1-mediated accumulation of platinum and oxaliplatin-induced neurotoxicity in vitro and in vivo.
Contributions of rat Ctr1 to the uptake and toxicity of copper and platinum anticancer drugs in dorsal root ganglion neurons.
Association of copper transporter expression with platinum resistance in epithelial ovarian cancer.
Resistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoprotein.
Penicillamine increases free copper and enhances oxidative stress in the brain of toxic milk mice.
Basal expression of copper transporter 1 in intestinal epithelial cells is regulated by hypoxia-inducible factor 2α.
Role of the copper transporter, CTR1, in platinum-induced ototoxicity.
Enhanced delivery of cisplatin to intraperitoneal ovarian carcinomas mediated by the effects of bortezomib on the human copper transporter 1.
Expression of the human copper influx transporter 1 in normal and malignant human tissues.
PET of human prostate cancer xenografts in mice with increased uptake of 64CuCl2.
The internalization and degradation of human copper transporter 1 following cisplatin exposure.
Schneider V, Chaib S, Spanier C, Knapp M, Moscvin V, Scordovillo L, Ewertz A, Jaehde U, Kalayda GV
The AAPS journal 2017 Nov 30;20(1):9
The AAPS journal 2017 Nov 30;20(1):9
Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells.
Doherty B, Lawlor D, Gillet JP, Gottesman M, O'Leary JJ, Stordal B
Anticancer research 2014 Jan;34(1):503-7
Anticancer research 2014 Jan;34(1):503-7
Evaluation of effects of copper histidine on copper transporter 1-mediated accumulation of platinum and oxaliplatin-induced neurotoxicity in vitro and in vivo.
Ip V, Liu JJ, McKeage MJ
Clinical and experimental pharmacology & physiology 2013 Jun;40(6):371-8
Clinical and experimental pharmacology & physiology 2013 Jun;40(6):371-8
Contributions of rat Ctr1 to the uptake and toxicity of copper and platinum anticancer drugs in dorsal root ganglion neurons.
Liu JJ, Kim Y, Yan F, Ding Q, Ip V, Jong NN, Mercer JF, McKeage MJ
Biochemical pharmacology 2013 Jan 15;85(2):207-15
Biochemical pharmacology 2013 Jan 15;85(2):207-15
Association of copper transporter expression with platinum resistance in epithelial ovarian cancer.
Yoshida H, Teramae M, Yamauchi M, Fukuda T, Yasui T, Sumi T, Honda K, Ishiko O
Anticancer research 2013 Apr;33(4):1409-14
Anticancer research 2013 Apr;33(4):1409-14
Resistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoprotein.
Stordal B, Hamon M, McEneaney V, Roche S, Gillet JP, O'Leary JJ, Gottesman M, Clynes M
PloS one 2012;7(7):e40717
PloS one 2012;7(7):e40717
Penicillamine increases free copper and enhances oxidative stress in the brain of toxic milk mice.
Chen DB, Feng L, Lin XP, Zhang W, Li FR, Liang XL, Li XH
PloS one 2012;7(5):e37709
PloS one 2012;7(5):e37709
Basal expression of copper transporter 1 in intestinal epithelial cells is regulated by hypoxia-inducible factor 2α.
Pourvali K, Matak P, Latunde-Dada GO, Solomou S, Mastrogiannaki M, Peyssonnaux C, Sharp PA
FEBS letters 2012 Jul 30;586(16):2423-7
FEBS letters 2012 Jul 30;586(16):2423-7
Role of the copper transporter, CTR1, in platinum-induced ototoxicity.
More SS, Akil O, Ianculescu AG, Geier EG, Lustig LR, Giacomini KM
The Journal of neuroscience : the official journal of the Society for Neuroscience 2010 Jul 14;30(28):9500-9
The Journal of neuroscience : the official journal of the Society for Neuroscience 2010 Jul 14;30(28):9500-9
Enhanced delivery of cisplatin to intraperitoneal ovarian carcinomas mediated by the effects of bortezomib on the human copper transporter 1.
Jandial DD, Farshchi-Heydari S, Larson CA, Elliott GI, Wrasidlo WJ, Howell SB
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Jan 15;15(2):553-60
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Jan 15;15(2):553-60
Expression of the human copper influx transporter 1 in normal and malignant human tissues.
Holzer AK, Varki NM, Le QT, Gibson MA, Naredi P, Howell SB
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2006 Sep;54(9):1041-9
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2006 Sep;54(9):1041-9
PET of human prostate cancer xenografts in mice with increased uptake of 64CuCl2.
Peng F, Lu X, Janisse J, Muzik O, Shields AF
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006 Oct;47(10):1649-52
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006 Oct;47(10):1649-52
The internalization and degradation of human copper transporter 1 following cisplatin exposure.
Holzer AK, Howell SB
Cancer research 2006 Nov 15;66(22):10944-52
Cancer research 2006 Nov 15;66(22):10944-52
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC